Placeholder Banner

Digital Health Preview

June 15, 2015
A short time ago, we held a webinar with three of the expert speakers who will be sharing their insights on digital health at the 2015 BIO International Convention later this week.

These speakers included

  • Wainwright Fishburn, Partner, Cooley LLP

  • Donald Jones, Chief Executive Officer, Trial Fusion

  • Julie Papanek, Principal, Canaan Partners


They outlined with us some of the major themes that you can expect to hear explored in depth in the digital health sessions in Philadelphia.  Themes such as how the pressure of social networking and the “internet of things” are altering the traditional balance of knowledge between patients and practitioners, with implications for designing clinical trials.  Also, they discuss how the venture capitalist investors eager to disrupt existing business models and sell direct to consumers are countered by industry players more experienced with health care’s pre-market regulatory requirements.

See the webinar video here:



With venture capitalists having already invested more than $4B this past year in digital health companies across a broad array of specialties, this sector’s influence will only grow, changing every part of the drug development lifecycle.

To see how these forces are already affecting you and your business, please attend Dr. Eric Topol’s keynote on Wednesday, June 17, at 12:00 PM in the Terrace Ballroom on level 400 of the Pennsylvania Convention Center, and the eleven panels on digital health opportunities, a record-setting number for BIO.

See the whole list of upcoming digital health panels and speakers here:

convention.bio.org/digitalhealth